Enlivex Therapeutics (NASDAQ:ENLV – Get Free Report) had its target price boosted by equities researchers at HC Wainwright from $20.00 to $80.00 in a report issued on Monday, Marketbeat Ratings reports. The firm currently has a “buy” rating on the stock. A number of other equities research analysts have also weighed in on ENLV. Weiss […]

Oruka Therapeutics (NASDAQ:ORKA – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They presently have a $120.00 price objective on the stock. HC Wainwright’s target price suggests a potential upside of 24.34% from the stock’s current price. Several other […]

Halozyme Therapeutics (NASDAQ:HALO – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $95.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target indicates a potential upside of 23.23% from the stock’s previous close. A […]